Galanin contributes to the excess colonic fluid secretion observed in dextran sulfate sodium murine colitis

Inflammatory Bowel Diseases

Volumn 10, Issue 4, 2004, Pages 408-416

  Matkowskyj, Kristina A ^a,b   Nathaniel, Rajkumar ^a,b   Prasad, Roli ^a   Weihrauch, Dirk ^a   Rao, Mrinalini ^a   Benya, Richard V ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Colitis; Diaarhea; Galanin 1 receptor; Inflammation; NF B

Indexed keywords

DEXTRAN SULFATE; GALANIN; GALANIN RECEPTOR; GALANIN RECEPTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; INTESTINE CELL; INTESTINE FLUID; INTESTINE SECRETION; NERVE CELL; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; WILD TYPE;

ANIMALS; ANTICOAGULANTS; COLITIS; COLON; DEXTRAN SULFATE; DIARRHEA; DISEASE MODELS, ANIMAL; GALANIN; GENOTYPE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; RECEPTOR, GALANIN, TYPE 1; WATER-ELECTROLYTE BALANCE;

EID: 3543112679     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-200407000-00012     Document Type: Article

References (33)

1. Miki K, Moore DJ, Butler RN, et al. The sugar permeability test reflects disease activity in children and adolescents with inflammatory bowel disease. J Pediatr. 1998;133:750-754.
2. Madsen KL, Malfair D, Gray D, et al. Interleukin-10 gene-deficient mice develop a primary intestinal permeability defect in response to enteric microflora. Inflamm Bowel Dis. 1999;5:262-270.
3. Lee CM, Kumar RK, Lubowski DZ, et al. Neuropeptides and nerve growth in inflammatory bowel diseases: a quantitative immunohistochemical study. Dig Dis Sci. 2002;47:495-502.
4. Tomita R, Tanjoh K, Fujisaki S, et al. Peptidergic nerves in the colon of patients with ulcerative colitis. Hepatogastroenterology. 2000;47:400-407.
5. Holzer P, Holzer-Petsche U. Tachykinin receptors in the gut: physiological and pathological implications. Curr Opin Pharmacol. 2001;1:583-590.
6. - secretion in the human colon. Potential significance of inflammation-associated NF-κB activation on galanin-1 receptor expression and function. Ann N Y Acad Sci. 1998;869:64-77.
7. - secretion. Am J Physiol. 1999;276:G64-G76.
8. - secretion from intestinal epithelia by upregulating galanin-1 receptor expression. J Clin Invest. 1999;104:253-262.
9. Marrero JA, Matkowskyj KA, Yung K, et al. Dextran sulfate sodium-induced murine colitis activates NF-κB and increases galanin-1 receptor expression. Am J Physiol. 2000;278:G797-G810.
10. Matkowskyj KA, Danilkovic A, Marrero JA, et al. Galanin-1 receptor up-regulation mediates the excess colonic fluid production caused by infection with enteric pathogens. Nature Med. 2000;6:1048-1051.
11. Rattan S. Role of galanin in the gut. Gastroenterology. 1991;100:1762-1768.
12. Lorimer DD, Matkowskjy K, Benya RV. Cloning, chromosomal localization, and transciptional regulation of the human galanin-1 receptor gene (GALN1R). Biochem Biophys Res Commun. 1997;241:558-564.
13. Wang YF, Mao YK, McDonald TJ, et al. Distribution of galanin-immunoreactive nerves in the canine gastrointestinal tract. Peptides. 1995;16:237-247.
14. Villar MJ, Cortes R, Theodorsson E, et al. Neuropeptide expression in rat dorsal root ganglion cells and spinal cord after peripheral nerve injury with special reference to galanin. Neuroscience. 1989;33:587-604.
15. Bauer FE, Zintel A, Kenny MJ, et al. Inhibitory effect of galanin on post-prandial gastrointestinal motility and gut hormone release in humans. Gastroenterology. 1989;97:260-264.
16. Okayasu I, Hatakeyama S, Yamada M, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990;98:694-702.
17. Castagliuolo I, Riegler M, Pasha A, et al. Neurokinin-1 (NK-1) receptor is required in Clostridium difficile-induced enteritis, J Clin Invest. 1998; 101:1547-1550.
18. Matkowskyj KA, Schonfeld D, Benya RV. Quantitative immunohistochemistry by measuring cumulative signal strength using commercially available software Photoshop and Matlab. J Histochem Cytochem. 2000; 48:303-311.
19. Matkowskyj KA, Cox R, Jensen RT, et al. Quantitative immunohistochemistry by measuring cumulative signal strength accurately measures protein concentration. J Histochem Cytochem. 2003;51:205-214.
20. Gu Z-F, Rossowski WJ, Coy DH, et al. Chimeric galanin analogs that function as antagonists in the CNS are full agonists in gastrointestinal smooth muscle. J Pharmacol Exp Ther. 1993;266:912-918.
21. Heuillet E, Bouaiche Z, Menager J, et al. The human galanin receptor: ligand-binding and functional characteristics in the Bowes melanoma cell line. Eur J Pharmacol. 1994;269:139-147.
22. Patterson J, Conklin D, Murphy K, et al. Pharmacological characterization of a recombinant human galanin receptor (GalR1) in HEK293 cells. Soc Neurosci. 23:392-397.
23. Yu J, Harden DG, Pitler TA, et al. Agonist properties of chimeric galanin peptides. Soc Neurosci. 23:393-397.
24. Walker MW, Smithe KE, Borowsky B, et al. Cloned galanin receptors: pharmacology of GalR1 and GalR2 receptor subtypes. Soc Neurosci. 23:962-997.
25. Sousa MM, Yan SD, Stern D, et al. Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor κB (NF-κB) activation. Lab Invest. 2000;80:1101-1110.
26. Kofler B, Evans HF, Liu MJ, et al. Characterization of the 5′-flanking region of the human preprogalanin gene. DNA Cell Biol. 1995;14:321-329.
27. Matsusaka T, Fujikawa K, Nishio Y, et al. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Natl Acad Sci U S A. 1993; 90:10193-10197.
28. Schmitz H, Barmeyer C, Fromm M, et al. Altered tight junction structure contributes to the impaired epithelial barrier fucntion in ulcerative colitis. Gastroenterology. 1999;116:301-309.
29. Lohi H, Makela S, Pulkkinen K, et al. Upregulation of CFTR expression but not SLC26A3 and SLC9A3 in ulcerative colitis. Am J Physiol. 2002; 283:G567-G575.
30. Schreiber S, Nikolaus S, Hampe J. Activation of nuclear factor κB in inflammatory bowel disease. Gut. 1998;42:477-484.
31. Neurath MF, Fuss I, Schurmann G, et al. Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease. Ann N Y Acad Sci. 1998;859:149-159.
32. Gu Z-F, Pradhan TK, Coy DH, et al. Interaction of galanin fragments with galanin receptors on isolated smooth muscle cells from Guinea pig stomach: identification of a novel galanin receptor subtype. J Pharmacol Exp Ther. 1995;272:371-378.
33. Yang HK, Scott FM, Trepel JB, et al. Correlation of expression of bombesin-like peptides and receptors with growth inhibition by an antibombesin antibody in small-cell lung cancer cell lines. Lung Cancer. 21:165-175.